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We developed a pre-clinical model in which to evaluate the impact of orally administered carbohydrates 
on postprandial blood glucose levels. For this purpose, we compared the effects of different carbohydrates 
with well-established glycemic indexes. We orally administered (gavage) increasing amounts (0.2, 0.4, 
0.6, 0.8, and 1.0 g/kg) of sucrose and lactose to rats which had been fasted for 6 h or 15 h, respectively. 
In part of the experiments we administered frutose (gavagem). Three different models were compared 
for measuring postprandial blood glucose levels: a) evaluation of interstitial glucose concentrations by 
using a real time continuous glucose monitoring system; b) evaluation of glucose levels in blood obtained 
from the rat tail; c) evaluation of serum glucose levels in blood collected after decapitation. Our results 
showed that blood obtained from the tails of 15-h fasted rats was the best model in which to evaluate 
the effect of carbohydrates on postprandial blood glucose levels.
Uniterms: Glycemic index/study. Glycemic index/oral administration. Glycemic load. Interstitial glucose. 
Real time continuous glucose monitoring system. Carbohydrates/posprandial glucose levels/rats.
INTRODUCTION
It is widely recognized that higher peak postprandial 
glucose (PPG) levels are associated with type 2 diabetes 
(Maki, Phillips, 2015), obesity (Thomas, Elliott, Baur, 
2007), cardiovascular diseases (Little et al., 2014), liver 
steatosis (Valtueña et al., 2006), and cancer (Esfahani et 
al., 2009). Several studies have shown that consuming a 
diet with a low glycemic index (GI) can reduce insulin 
resistance (König et al., 2014), blood lipid concentrations 
(Levitan et al., 2008), body weight (Krebs et al., 2013), 
and the levels of glycated hemoglobin (Wang et al., 
2015a) and pro-inflammatory markers (Feliciano, das 
Graças, Alfenas, 2014) in blood. Other studies have 
shown low GI diets to be associated with increased satiety 
(Pardo-Beutimea et al., 2012) and the incidence of cancer 
(Truong, Yuet, Hall, 2014).
The GI is a number which reflects how equal 
quantities of different types of carbohydrates affect 
an individual’s PPG level (Png et al., 2014; Wang et 
al., 2015b), and provides a measure of carbohydrate 
quality (Hollenbeck, Coulston, 1991). Furthermore, the 
PPG level can be predicted with reasonable accuracy 
from the GI, when a standard mixed meal (Wolever, 
Jenkins, 1986) or carbohydrate is consumed (Hashimoto, 
Noguchi, Furutani, 2014). Another index, glycemic load 
(GL), is calculated by multiplying the GI by the amount 
of carbohydrate, and then dividing that result by 100 
(Brand-Miller et al., 2003).
Today, GI and GL values are calculated based on the 
results of tests performed in humans (Frost, Dornhorst, 
2000; Jenkins et al., 1981; Recio-Rodriguez et al., 2015). 
However, these tests require the participation of volunteer 
subjects, and are expensive and very time-consuming to 
perform. Because only a few laboratories worldwide can 
perform these evaluations. GI and GL data are available 
for only a small number of foods (Foster-Powell, Holt, 
Brand-Miller, 2002). Interestingly, the GI and GL of the 
typical diet consumed in the USA appear to have risen in 
recent years, due to that nation’s increased carbohydrate 
consumption and changes in food-processing technology 
(Ludwig, 2002).
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When considering that manufacturers are creating 
new food products at a much faster rate than GI and GL 
testing can be performed, the utilization of pre-clinical 
models to reproduce the results obtained from GI and 
GL tests conducted in humans has become increasingly 
necessary.
In this regard, non-diabetic rats can be used to 
evaluate the effect of oral carbohydrates on blood glucose 
levels (Bassoli et al., 2008). The main advantage of this 
model is that non-diabetic rats maintain their mechanisms 
needed to prevent postprandial hyperglycemia, and can be 
studied without interference caused by insulin deficiency 
(Kabir et al., 1998). 
Our current study was conducted to identify a pre-
clinical model in which to evaluate the impact of orally 
administered carbohydrates on PPG levels, and that better 
simulates results obtained in humans. For this purpose, we 
compared the effects of three different carbohydrates with 
well-established GI values (sucrose, lactose, and fructose), 
and that represent typical sugars consumed in the Western 
diet. Additionally, we evaluated the effects of fasting time, 
the amount of carbohydrate administered, as well as the 
techniques used to measure glucose concentration. 
MATERIAL AND METHODS
Animals
Male Wistar adult rats (Rattus norvegicus) weighing 
280-330 g were used in this study. The rats were housed 
under condictions of constant temperature (23 ± 2 ºC), 
an automatically controlled photoperiod (12 h light/12 
h dark), and free access to food and water. The rats were 
fed a standard commercial laboratory diet (Nutrilab CR1, 
Curitiba, PR, Brazil) ad libitum prior to undergoing the 
experimental procedures.
The rodent chow was composed of the proteins 
(22%), fibers (8%), minerals (10%), calcium (1.4%) and 
phosphorus (0.8%). Each kilogram of this product was 
enriched with the metionine (300 mg), lysine (100 mg), 
antioxidant (100 mg), vitamin A (12.000 IU), vitamin 
D3 (1.800 IU), vitamin E (30 mg), vitamin C (800 mg), 
vitamin K3 (3 mg), vitamin B1 (5 mg), vitamin B2 (6 mg), 
vitamin B6 (7 mg), vitamin B12 (20 µg), niacine (60 mg), 
pantotenic acid (20 mg), folic acid (1.0 mg), biotine (0.05 
mg), coline (600 mg), iron (50 mg), zinc (60 mg), copper 
(10 mg), iodine (2 mg), manganese (60 mg), selenium 
(0.05 mg) and cobalt (1.5mg).
The rats were fasted for either 6 h or 15 h prior 
to starting the experiments. All procedures used in this 
study were approved by the Ethics Committee of the 
State University of Maringá (Brazil), and were performed 
in accordance with guidelines provided by the Brazilian 
Council on Animal Experimentation (protocol number: 
005/2013).
Experimental Protocol
Each carbohydrate (sucrose, lactose, and fructose) 
was dissolved in water (2.0 mL) for oral administration 
(gavage) to the rats.
Increasing amounts (0.2, 0.4, 0.6, 0.8, and 1.0 g/kg) 
of either sucrose or lactose were administered. In the final 
set of experiments, sucrose (0.8 g/kg), lactose (0.8 g/kg), 
fructose (0.8 g/kg) or both sucrose (0.4 g/kg) and fructose 
(0.4 g/kg) were administered. In all experiments, rats in 
the control group received the same volume (2.0 mL) of 
vehicle (water).
In the first set of experiments, changes in interstitial 
glucose concentration (IGC) were evaluated with a real-
time continuous glucose monitoring system (RT-CGMS). 
The main advantages of using that system were that it 
reduced the numbers of animals required for the study, 
and permitted a greater number of glucose measurements 
to be obtained from each animal (Sybuia et al., 2014). The 
RT-CGMS is described in our previously published study 
(Carrara et al., 2012). 
In the second set of experiments, the blood glucose 
concentrations (BGC) were determined by analyzing 
blood obtained from the tail of each animal at 0, 5, 15, 
30, and 60 min after oral administration of the selected 
carbohydrate. For this purpose, a drop of blood was 
obtained after a small incision was made at the tip of the 
tail, and its glucose level was determined using a home 
glucometer (Diagnostics Accu-Chek® Active glucometer 
- Roche Diagnostics; Jaguaré, Brazil). 
In the third set of experiments, the animals were 
sacrificed by decapitation; after which, samples of blood 
were gathered and examined for their serum glucose 
concentrations using the glucose oxidase method 
(Bergmeyer, Bernt, 1974) as previously described 
(Zubioli et al., 2011). The results reflected blood glucose 
concentrations at 0, 5, 15, 30, and 60 min after oral 
administration of the selected carbohydrate.
In the final set of experiments, blood was obtained 
from the tails of 15 h-fasted rats at 0, 5, 15, 30 and 60 
min after oral administration of either sucrose (0.8 g/kg), 
lactose (0.8 g/kg), fructose (0.8 g/kg), or sucrose (0.4 g/
kg) plus fructose (0.4 g/kg). 
Depending on their assigned group, the rats were 
sacrificed by decapitation or euthanized with a high dose 
(100 mg/kg) of intravenous thiopental (BGC and IGC 
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groups), and then injected with a lethal dose of potassium 
chloride (2 mM into the heart).
Statistical Procedures
All data were analyzed by one way ANOVA (Tukey 
post hoc test) that was performed using Graph-Pad Prism 
Version 5.0 software. Differences between the glucose 
concentration values before (time 0) and after (time 0 up to 
60 minutes) an oral dose of carbohydrate were calculated 
as an area under the curve (AUC). 
Individual and AUC results (expressed as mg/dL) 
are reported as the mean ± standard error of the mean. 
P-values < 0.05 were considered statistically significant. 
RESULTS
There was a significant (p<0.05) increase in the 
AUC for IGC after oral administration of either sucrose 
(0.6 or 0.8 g/kg) or lactose (0.6, 0.8 or 1.0 g/kg) to 
6-h fasted rats (Table I). There was also a significant 
(p < 0.05) increase in the AUC for IGC after oral 
administration of either sucrose (0.4, 0.6, 0.8 or 1.0 g/kg) 
or lactose (0.6, 0.8 or 1.0 g/kg) to 15-h fasted rats 
(Table II), when compared with the corresponding 
changes seen vehicle-dosed control rats. However, 
we did not observe such increased AUCs for glucose 
concentrations in samples of tail blood (Table III) or 
blood collected after decapitation (Table IV). 
We also observed a significantly (p<0.05) increased 
AUC for glucose levels after analyzing samples of tail 
blood collected from 15-h fasted rats, which after being 
fasted, received an oral dose of either sucrose (0.4, 0.6, 
0.8 or 1.0 g/kg) or lactose (0.2, 0.4, 0.6, 0.8 or 1.0 g/kg) 
(Table III). A similar increased AUC for glucose was found 
after analyzing samples of decapitation blood (p<0.05) 
collected from 15-h fasted rats, which after being fasted, 
received an oral dose of sucrose (0.2, 0.4, 0.6, 0.8, 1.0 g/
kg) or lactose (1.0 g/kg). These increases in glucose AUC 
values were relative to glucose AUC values which were 
calculated for control rats that were dosed with vehicle 
(Table IV).
The greatest differences between sucrose and lactose 
in terms of glycemic changes (individual values or AUC) 
were observed in samples of blood collected from 15-h 
fasted decapitated rats (Table IV). On the other hand, the 
AUCs that best reflected the GI values of sucrose and 
lactose were obtained when analyzing blood collected 
from 15-h fasted decapitated rats which received a 
0.8 g/kg oral dose of those same carbohydrates (Table IV).
As shown in Table V, the results for sucrose 
(0.8 g/kg) and lactose (0.8 g/kg) were very similar to 
those described in Table IV. Moreover, the results confirm 
the greater effect of sucrose compared to lactose on 
TABLE I - Interstitial glucose concentrations (IGCs) as measured with a continuous glucose monitoring system (mg/dL) in 6-h-fasted 
rats which received increasing oral doses of sucrose or lactose. The control group received vehicle. Data are expressed as the mean 
± standard error of the mean for results obtained from 3-6 rats. AUC: area under the curve
Time  
(min)
Vehicle
Sucrose (g/kg) Lactose (g/kg)
0.2 0.4 0.6 0.8 1.0 0.2 0.4 0.6 0.8 1.0 
 n = 5 n = 6 n = 5 n = 4 n = 5 n = 4 n = 3 n = 5 n = 4 n = 5 n = 6
0 89.3±7.7 95.2±4.3 84.7±1.9 87.0±7.3 86.4±9.2 81.6±2.9 82.4±8.5 84.7±4.0 90.0±10.9 68.0±6.4 80.0±6.1
5 90.7±7.4 96.4±5.5 86.0±2.4 91.7±7.8 88.8±9.5 84.4±2.4 83.6±9.1 85.0±4.9 95.2±11.1 75.1±7.2 84.4±6.7
10 88.0±7.2 100.8±6.4 92.3±2.6 102.0±8.7 97.2±9.4 92.2±2.7 89.6±9.7 89.0±5.6 106.0±10.8 84.3±8.1 93.6±5.7
15 86.7±6.6 104.8±5.9 100.0±2.2* 110.0±8.9 109.0±9.8 101.6±2.5* 96.0±9.4 96.0±5.8 114.0±10.7 90.6±7.8 103.0±4.7
20 86.7±5.7 107.6±5.1 105.0±1.7* 113.0±8.8 118.0±9.7 108.0±2.0* 99.2±8.9 103.0±6.2 118.0±10.5 93.7±6.8 109.0±4.3*
25 87.3±3.5 107.2±4.8 105.0±2.0* 112.0±8.2 120.0±9.5 107.6±2.6* 98.0±7.7 106.0±6.9 118.0±10.6 94.3±6.2 112.0±4.7*
30 86.7±3.5 104.8±4.1 102.0±3.0* 107.0±7.6 118.0±9.0 104.0±4.2* 94.8±6.6 106.7±7.6 115.6±10.9 92.8±6.3 111.6±5.5*
35 84.7±3.5 102.0±4.2 96.7±4.2* 100.7±7.3 113.0±8.0 98.0±4.7 93.2±6.5 104.3±7.4 111.6±10.6 91.1±6.5 108.0±6.2*
40 83.3±5.2 98.0±4.0 91.3±5.3 93.7±7.3 108.0±7.1 93.2±4.7 91.6±6.3 99.3±6.1 107.0±10.5 89.1±6.7 106.0±5.8*
45 83.3±5.9 95.2±4.0 87.3±5.3 89.3±7.5 103.0±6.7 88.0±3.9 88.8±6.1 96.0±5.6 103.0±10.6 86.3±7.0 104.0±5.3
50 84.7±5.4 94.0±4.3 84.0±5.6 86.3±7.6 98.4±7.2 84.0±4.2 86.4±5.4 93.0±5.0 99.6±10.7 83.4±7.4 102.0±5.0
55 83.3±5.9 93.6±4.9 81.0±6.0 85.0±7.9 94.4±8.5 82.0±4.5 84.8±5.0 91.0±4.9 97.6±11.0 80.9±7.5 101.6±4.6
60 82.0±5.2 94.0±4.7 80.3±5.4 84.3±8.1 93.2±8.3 82.0±4.2 82.8±5.3 88.3±5.5 96.0±11.8 78.0±7.9 102.0±4.7
AUC  6.0±2.9 20.8±2.3 33.0±5.3 48.0±6.6a 56.6±3.5a 39.6±6.3 31.0±6.0 37.3±6.9 57.8±5.4a 59.6±7.8a 69.8±7.2a
* In the same column indicate p <0.05 vs. time 0. a In the same line indicate p <0.05 vs. vehicle.
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TABLE II - Interstitial glucose concentrations (IGCs) as measured with a continuous glucose monitoring (mg/dL) system in 
15-h-fasted rats which received increasing oral doses of sucrose or lactose. The control group received vehicle. Data are expressed 
as the mean ± standard error of the mean for results obtained from 3-4 rats. AUC: area under the curve
Time  
(min)
Vehicle
Sucrose (g/kg) Lactose (g/kg)
0.2 0.4 0.6 0.8 1.0 0.2 0.4 0.6 0.8 1.0 
n = 4 n = 4 n = 4 n = 4 n = 4 n = 3 n = 4 n = 4 n = 4 n = 3 n = 3
0 82.0±6.0 85.0±1.3 69.5±10.0 68.7±7.9 67.0±10.5 75.3±7.0 84.0±7.8 80.0±9.8 82.0±11.6 83.0±4.5 79.3±9.3
5 82.0±6.9 89.0±1.3 71.5±9.3 71.3±8.5 69.0±10.9 80.7±6.7 87.0±9.4 81.0±10.1 82.5±13.0 87.5±5.1 81.3±9.3
10 83.0±7.2 90.0±2.4 76.5±9.3 78.0±8.3 75.5±10.6 91.3±7.7 90.5±9.9 82.5±10.4 87.5±13.6 97.0±6.2 86.0±8.0
15 83.5±8.1 91.5±3.7 84.5±9.5 87.3±7.7 85.5±10.3 106.0±7.2 94.0±9.6 87.5±10.5 93.5±14.1 107.5±6.2 93.3±6.6
20 83.5±8.1 93.0±4.2 91.5±9.7 94.7±7.0 92.5±9.1 118.7±5.7* 95.5±8.8 93.0±9.9 99.0±14.4 114.0±5.8* 100.7±7.0
25 82.5±7.9 94.5±3.1 94.5±10.0 98.0±7.2 95.0±9.0 122.7±7.0* 93.0±7.5 95.5±10.1 100.5±13.6 116.5±5.2* 106.7±9.0
30 80.5±7.9 97.5±0.9 93.0±10.4 96.7±7.7 97.5±8.6 120.0±9.2* 90.0±7.0 95.0±9.2 99.5±11.5 115.0±5.4* 109.3±10.3
35 80.5±7.1 98.5±3.8 88.5±10.9 92.7±7.7 98.5±8.6 112.7±9.2* 87.0±6.2 92.0±8.7 98.0±9.6 111.5±6.3* 107.3±12.4
40 80.0±6.3 95.0±4.2 83.0±11.6 88.0±8.1 95.5±8.4 107.3±8.2 85.0±5.3 87.5±8.3 96.0±8.5 106.5±5.9 104.0±13.3
45 79.0±5.1 91.0±4.4 78.0±12.6 84.0±8.1 93.0±7.5 103.3±7.0 81.0±5.2 83.5±8.3 93.0±7.3 102.0±5.0 101.3±12.7
50 78.5±4.9 88.0±4.5 75.5±12.3 80.0±8.1 90.0±8.0 100.7±5.8 79.5±5.6 80.5±8.9 91.0±7.3 98.5±4.2 99.3±11.6
55 77.0±4.6 84.5±4.7 73.0±11.6 77.3±8.3 86.0±8.5 97.3±5.9 78.0±5.8 78.0±9.5 89.0±7.1 96.0±4.1 98.0±10.1
60 76.0±5.7 82.0±5.0 72.0±11.1 75.3±8.3 82.5±8.6 93.3±6.4 77.5±6.7 76.5±9.9 88.0±7.5 95.0±4.0 94.7±9.7
AUC 10.5±3.7 21.2±2.9 41.2±3.8a 52.6±1.3a 58.7±4.5a 89.7±5.9a 17.0±2.4 17.2±2.8 34.2±2.0a 67.0±4.7a 53.7±3.2a
* In the same column indicate p <0.05 vs. time 0. a In the same line indicate p <0.05 vs. vehicle.
TABLE III - Glucose concentrations in samples of blood collected from the tail as measured with a home glucometer (mg/dL). The 
rats were fasted for either 6 h or 15 h, and then received increasing oral doses of sucrose or lactose. The control group received 
vehicle. Data are expressed as the mean ± standard error of the mean for results obtained from 3-6 rats. AUC: area under the curve
6-h-fasted rats
Time  
(min)
Vehicle
Sucrose (g/kg) Lactose (g/kg)
0.2 0.4 0.6 0.8 1.0 0.2 0.4 0.6 0.8 1.0 
n = 4 n = 3 n = 3 n = 3 n = 5 n = 3 n = 3 n = 3 n = 4 n = 5 n = 4
0 92.8±4.5 99.7±6.2 105.3±4.8 99.3±6.5 95.0±6.4 102.6±1.2 102.3±8.5 95.2±4.1 96.7±3.7 102.8±1.4 95.5±3.0
5 105.8±8.5 117.0±6.0 105.3±3.3 118.7±18.2 102.7±9.4 107.8±4.1 117.3±12.4 103.6±8.6 110.7±4.4 121.3±4.8* 98.0±4.3
15 114.5±3.2* 115.0±4.5 129.0±7.8 135.0±10.5 137.3±5.8* 125.2±4.0* 129.0±11.3 121.8±7.4* 110.7±4.7 124.0±2.5* 109.0±7.0
30 117.0±3.2* 116.0±2.6 132.3±8.5 131.0±3.2 128.7±3.8* 128.6±2.5* 130.7±5.4 122.8±1.3* 119.3±3.2* 128.5±1.5* 121.0±1.9*
60 115.8±2.1* 115.0±3.2 115.7±4.3 110.3±2.2 114.0±5.1 125.4±4.1* 115.3±2.7 117.4±1.3 113.3±4.8 123.8±4.7* 109.3±4.2
AUC 74.2±7.9 56.7±10.2 68.0±12.1 92.2±4.7 93.2±6.4 67.1±7.4 73.8±9.9 75.5±5.4 59.0±9.6 76.0±4.1 51.0±4.7
15-h-fasted rats 
Time 
(min)
Vehicle
Sucrose (g/kg) Lactose (g/kg)
0.2 0.4 0.6 0.8 1.0 0.2 0.4 0.6 0.8 1.0 
n = 5 n = 4 n = 5 n = 4 n = 5 n = 4 n = 5 n = 5 n = 5 n = 3 n = 6
0 76.2±3.9 81.7±3.8 77.5±1.4 75.5±3.0 79.3±5.9 81.0±2.0 75.8±2.6 73.4±1.5 74.2±2.4 78.0±2.0 73.7±3.0
5 78.2±4.5 86.2±2.1 83.5±3.7 77.7±2.1 94.3±5.9 79.6±2.2 85.8±3.4 77.6±4.4 89.0±6.0* 87.4±2.6 87.7±3.4
15 83.0±5.0 108.5±8.9* 114.5±6.0*a 113.0±4.3*a 131.7±5.0*a 110.0±6.5* 103.0±6.3* 96.6±4.7* 103.6±2.8* 112.2±1.1*a 104.8±5.7*
30 96.8±4.0* 119.0±5.5* 127.5±5.7*a 147.0±5.9*a 157.7±11.6*a 139.7±9.9*a 115.8±4.1* 115.8±3.4* 125.4±3.2*a 130.8±4.9*a 131.2±4.8*a
60 88.4±0.8 96.75±3.2 103.8±2.9* 111.3±6.3* 114.7±6.2*a 118.7±4.6*a 101.4±3.6* 106.2±4.1* 119.4±7.0*a 124.4±5.5*a 127.5±5.4*a
AUC 36.8±5.8 85.6±9.8 111.1±5.9a 134.4±10.6a 164.8±13.4a 110.3±1.7a 90.0±5.2a 95.5±9.9a 118.0±6.7a 123.3±10.8a 131.1±15.0a
a In the same line indicates p <0.05 vs. vehicle.
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TABLE IV - Serum glucose concentrations in blood collected from decapitated rats as measured with standard commercial kits 
(mg/dL). The rats were fasted for either 6 h or 15 h, and then received increasing oral doses of sucrose or lactose. The control 
group received vehicle. Data are expressed as mean ± standard error of the mean for results obtained from 2-6 rats. AUC: area 
under the curve
6-h-fasted rats
Time 
(min)
Vehicle
Sucrose (g/kg) Lactose (g/kg)
0.2 0.4 0.6 0.8 1.0 0.2 0.4 0.6 0.8 1.0
0 127.7±3.2 
(3)
133.6±4.5 
(4)
138.0±1.7 
(3)
135.0±6.4 
(3)
138.0±5.2 
(3)
130.4±3.8 
(4)
 136.6±6.6 
(4)
 135.7±5.7 
(4)
137.4±6.0 
(3)
136.4±3.2 
(4)
 142.4±4.2 
(4)
5 158.8±3.4* 
(3)
158.3±9.2 
(4)
177.6±16.3 
(3)
174.3±3.7* 
(3)
176.2±5.8* 
(3)
167.9±6.2* 
(4)
141.5±3.6 
(4)
157.5±10.6 
(4)
169.7±5.8* 
(2)
172.8±2.8* 
(4)
161.9±15.9 
(4)
15 154.0±6.5* 
(3)
160.2±4.7 
(4)
157.0±3.2 
(3)
152.0±8.2 
(3)
156.7±8.5 
(2)
152.0±2.6* 
(4)
142.2±1.4 
(4)
137.0±4.5 
(4)
156.0±0.9 
(3)
162.0±4.4* 
(4)
163.7±3.7 
(4)
30 139.6±6.4 
(3)
130.6±5.2 
(4)
130.0±4.2 
(3)
133.0±8.3 
(3)
130.0±4.0 
(2)
150.5±5.4 
(4)
133.0±12.5 
(4)
137.6±7.2 
(4)
141.6±2.3 
(3)
141.2±9.5 
(4)
144.2±7.2 
(4)
60 129.2±4.4 
(3)
132.9±6.2 
(4)
144.7±11.9 
(3)
133.5±6.4 
(3)
136.8±2.8 
(3)
137.2±4.5 
(4)
125.9±7.7 
(4)
122.2±4.2 
(4)
128.9±5.3 
(3)
129.1±2.8 
(4)
137.1±5.5 
(4)
AUC 66.1±1.9 66.9±7.2 74.6±2.7 57.1±8.5 56.5±7.5 78.4±8.2 15.5±6.0a 28.9±7.0 45.8±5.9 58.0±8.5 63.9±13.6
15-h-fasted rats
0 95.0±1.6 
(5)
95.2±2.1 
(6)
91.4±1.5 
(5)
94.3±3.0 
(4) 
95.7±3.1 
(5)
94.0±2.0 
(4)
100.0±5.1 
(3)
94.3±2.5 
(5)
89.4±4.0 
(4) 
99.2±3.0 
(5)
95.4±3.6 
(6)
5 102.7±1.9 
(5)
126.5±4.2*a 
(6)
124.1±7.6* 
(5)
128.9±3.8*a 
(4)
138.8±7.4*a 
(5)
138.7±5.1*a 
(4)
104.7±3.7 
(3)
115.2±7.1 
(5)
108.6±5.9 
(4)
107.7±2.4 
(5)
117.4±3.5* 
(6)
15 111.4±4.7* 
(5)
142.4±6.3*a 
(6)
166.2±7.6*a 
(5)
164.8±4.2*a 
(4)
176.6±6.1*a 
(5)
179.6±7.8*a 
(4)
129.4±6.1* 
(3)
136.1±6.3* 
(5)
113.5±10.3 
(4)
131.4±4.5* 
(5)
139.3±5.8* 
(6)
30 103.4±4.1 
(5)
118.8±5.3* 
(6)
134.9±3.8*a 
(5)
140.5±7.0*a 
(4)
143.0±4.5*a 
(5)
160.2±6.0*a 
(4)
112.6±7.2 
(3)
114.7±4.5 
(5)
115.2±1.9 
(4)
134.4±6.9*a 
(5)
121.7±2.3* 
(6)
60 89.1±2.7 
(5)
102.1±2.5 
(6)
101.6±1.8 
(5)
111.5±6.1a 
(4)
111.4±2.1a 
(5)
119.6±4.7*a 
(4)
104.5±3.5 
(3)
109.2±4.4a 
(5)
113.9±5.3a 
(4)
115.5±4.3a 
(5)
114.2±5.5*a 
(6)
AUC 37.7±3.0 117.0±9.0a 156.3±11.2a 160.0±15.8a 179.2±15.2a 207.0±16.7a 68.3±10.4 90.7±13.2 81.5±19.9 84.2±5.0 99.7±11.6a
* In the same column indicate p <0.05 vs. time 0. a In the same line indicate p <0.05 vs. vehicle.
TABLE V - Blood glucose concentrations in samples of tail blood obtained from 15-h fasted rats which received sucrose, lactose, 
fructose or sucrose + fructose, as measured with a home glucometer (mg/dL). The control group received vehicle. The individual 
values (0, 5, 15, 30, 60 min) and the areas under the curve (AUC) are expressed as the mean ± standard error for results obtained 
from 4 rats
Time
(min)
Vehicle
Sucrose Lactose Fructose Sucrose + Fructose 
0.8 (g/kg) 0.8(g/kg) 0.8 (g/kg) 0.4 (g/kg) + 0.4 (g/kg) 
n = 4 n = 4 n = 4 n = 4 n = 4
0 79.0±2.4 79.1±2.3 77.8±4.1 77.6±3.6 76.9±4.2
5 85.5±3.5* 87.8±2.6* 84.1±4.2* 79.1±3.3 82.8±3.2
15 104.3±4.5* 133.9±5.5*abc 105.5±4.0* 103.1±6.1* 114.1±8.2*
30 106.1±3.1* 159.4±3.8 *abcd 135.1±3.5*a 124.6±3.4*a 139.4±4.6*a
60 92.1±3.4* 118.6±1.9*a 123.4±2.4*ad 110.9±2.8*a 115.5±3.8*a
AUC 69.9±12.7 167.7±11.0ac 117.3±14.6 102.8±9.8 129.2±18.0a
* In the same column indicate p<0.05 vs. time 0. Letters in the same line: a p<0.05 vs. vehicle, b p<0.05 vs. lactose, c p<0.05 vs. 
fructose, d p<0.05 vs. sucrose + fructose
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post-prandial glucose (PPG) levels Finally, the amount 
of sucrose or lactose administered (GL) had minimal 
influence (individual values or AUC) on the glucose 
concentrations in blood collected from the tail (Table III) 
or after decapitation (Table IV), not only in 6-h fasted rats, 
but also in 15-h fasted rats. 
DISCUSSION
We found that the period of fasting influenced 
the PPG response to an oral dose of sucrose or lactose. 
However, we did not observe an increase in the AUC of 
PPG in blood obtained from the tail or after capitation of 
6-h fasted rats which received an oral dose of sucrose or 
lactose (Tables III and IV).
In contrast, we observed a significant (p < 0.05) 
increase in the AUC for IGC (vs. vehicle) after a dose 
of sucrose (0.6 or 0.8 g/kg) or lactose (0.6, 0.8 or 1.0 
g/kg) in 6-h fasted rats (Table I). Taken together, these 
results suggest that when using a more physiological 
period of fasting, (i.e., 6-h of food deprivation), IGC 
measurements more accurately reflect PPG levels after 
an oral administration of carbohydrates. However, despite 
our expectation that a higher GL would result in a higher 
peak PPG level (Atkinson, Foster-Powell, Brand-Miller, 
2008; Brand-Miller et al., 2003; Liu et al., 2000; Venn et 
al., 2006), we did not observe a clear relationship between 
the GL and PPG levels, not only for the IGC/6-h fasted 
rats, but for all of the experimental conditions investigated. 
On the other hand, increased IGCs (p < 0.05 vs. 
vehicle) (Table II), were detected in tail blood (Table 
III) and decapitation blood (Table IV) obtained from 
15-h fasted rats which received an oral dose of sucrose 
or lactose. The superior accuracy achieved when using 
a longer fasting period might be attributable to less 
interference from liver glycogenolysis (Schiavon et al., 
2014; Tavoni et al., 2013). 
Although the values for interstitial glucose and PPG 
concentrations in tail blood and decapitation blood obtained 
from 15-h fasted rats were better correlated with the amount 
of carbohydrate administered when compared with those 
values in 6-h fasted rats, the PPG values obtained from tail 
blood may be preferable to the IGC values obtained from 
decapitation blood when seeking a reliable test for PPG 
levels in rats. This notion is based on the fact that the AUC 
values obtained from tail blood more accurately reflect 
the GI values of sucrose (GI = 59) and lactose (GI = 46) 
in humans, and particularly when those carbohydrates are 
administered at doses of 0.6, 0.8, and 1.0 g/kg. For example, 
when administered at a dose of 0.8 g/kg, the AUC values 
obtained for sucrose and lactose in decapitation blood 
were 179.2 ± 15.2 mg/dL and 84.2 ± 5.0 mg/dL (Table IV) 
respectively, i.e., a mathematical proportion of 59 (sucrose) 
to 28 (lactose). On the other hand, the AUC values for 
sucrose and lactose in tail blood were 164.8 ± 13.4 mg/
dL and 123.3 ± 10.8 mg/dL (Table III), respectively, i.e., 
a mathematical proportion of 59 (sucrose) to 44 (lactose). 
Thus, the AUC values obtained with tail blood better reflect 
the GI values of sucrose (Jenkins et al., 1981) and lactose 
(Foster-Powell, Holt, Brand-Miller, 2002) in humans.
Despite the advantages of using a RT-CGMS to 
measure IGC values (Sybuia et al., 2014), that technique 
less often reproduced the results obtained from GI tests 
in humans.
In the last set of experiments blood was obtained 
from the tails of 15 h-fasted which received either sucrose 
(0.8 g/kg), lactose (0.8 g/kg) or fructose (0.8 g/kg), or a 
mixture of sucrose (0.4 g/kg) plus fructose (0.4 g/kg). 
The results (Table V) obtained when using sucrose 
(0.8 g/kg) or lactose (0.8 g/kg) were very similar to those 
shown in Table III. When using tail blood, the AUC values 
for sucrose and lactose were 167.7 ± 11.3 mg/dL and 117.3 
± 14.6 mg/dL (Table V), respectively; i.e., a mathematical 
proportion of 59 (sucrose) to 41 (lactose), and once again, 
better reflected the GI values of sucrose (GI = 59) and 
lactose (GI = 46) in humans. Moreover, as we expected, 
fructose (GI = 20) showed a lower (p < 0.05) AUC than did 
sucrose or the 50%/50% mixture of sucrose and fructose, 
which showed an AUC value intermediate between those 
of sucrose and fructose.
In contrast to our current results, past investigations 
concerning the impact of isolated carbohydrates or mixed 
foods on human blood glucose levels have shown great 
variability among the tested individuals, which have 
included healthy subjects, as well as pre-diabetic and 
diabetic subjects (Atkinson, Foster-Powell, Brand-Miller, 
2008). Moreover, inter-individual and intra-individual 
variations (Vega-López et al., 2007), the placebo effect 
(Sievenpiper et al., 2007), and several other factors (Foster-
Powell, Holt, Brand-Miller, 2002; Wolever et al., 2009) that 
can influence such results must be taken into consideration. 
In this context, using rats whose blood had been analyzed 
using a standardized methodology provides many 
advantages. For example, it is possible to control several 
variables which might influence the study results, including 
age, gender, strain, body weight, feeding schedule, period of 
fasting, and room temperature (Iannaccone, Jacob, 2009). 
CONCLUSION
Tail blood obtained from 15-h fasted rats represents 
the best pre-clinical model in which to evaluate the impact 
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of carbohydrates on PPG levels, and then extrapolate the 
results to humans.
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